Inventor · disambiguated record
Orion D. Jankowski
Also filed as: JANKOWSKI ORION · JANKOWSKI ORION D
23 granted patents·10 pending applications·349 citations·filing 2000–2022
96Inventor score
Files withJANKOWSKI ORION D7EDISON PHARMACEUTICALS INC6PTC THERAPEUTICS INC6BIOELECTRON TECH CORP3TYCO ELECTRONICS CORP3
Top patents by PatentIndex Score
33 records- 0198US7968746B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesEDISON PHARMACEUTICALS INC·Filed 2008·Granted Jun 28, 2011·46 cites·14 claims
- 0297US8575369B2Process for the production of alpha-tocotrienol and derivativesWESSON KIERON E·Filed 2012·Granted Nov 5, 2013·34 cites·28 claims
- 0397US8106223B2Process for the production of alpha-tocotrienol and derivativesWESSON KIERON E·Filed 2009·Granted Jan 31, 2012·46 cites·28 claims
- 0496US8519001B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesJANKOWSKI ORION D·Filed 2011·Granted Aug 27, 2013·30 cites·20 claims
- 0595US9169196B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesEDISON PHARMACEUTICALS INC·Filed 2013·Granted Oct 27, 2015·11 cites·24 claims
- 0695US8716527B22-substituted-p-quinone derivatives for treatment of oxidative stress diseasesHINMAN ANDREW W·Filed 2009·Granted May 6, 2014·35 cites·14 claims
- 0794US8716486B22-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseasesHINMAN ANDREW W·Filed 2009·Granted May 6, 2014·37 cites·31 claims
- 0892US8067395B2Inhibitors of tyrosine kinases and uses thereofJANKOWSKI ORION D·Filed 2009·Granted Nov 29, 2011·17 cites·20 claims
- 0991US9278085B2Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkersMILLER GUY M·Filed 2007·Granted Mar 8, 2016·19 cites·14 claims
- 1089US7625880B2Inhibitors of tyrosine kinases and uses thereofPHARMACYCLICS INC·Filed 2006·Granted Dec 1, 2009·9 cites·20 claims
- 1187US10071978B2Process for the production of alpha-tocotrienol and derivativesBIOELECTRON TECH CORP·Filed 2016·Granted Sep 11, 2018·3 cites·16 claims
- 1284US6987440B2Electrical devices containing conductive polymersTYCO ELECTRONICS CORP·Filed 2003·Granted Jan 17, 2006·14 cites·10 claims
- 1384US6531950B1Electrical devices containing conductive polymersTYCO ELECTRONICS CORP·Filed 2000·Granted Mar 11, 2003·15 cites·19 claims
- 1483US9090576B22-substituted-p-quinone derivatives for treatment of oxidative stress diseasesEDISON PHARMACEUTICALS INC·Filed 2014·Granted Jul 28, 2015·3 cites·22 claims
- 1583US6593843B1Electrical devices containing conductive polymersTYCO ELECTRONICS CORP·Filed 2000·Granted Jul 15, 2003·14 cites·12 claims
- 1683US2022204469A1Process for the production of alpha-tocotrienol and derivativesPTC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1781US9932286B2Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkersBIOELECTRON TECH CORP·Filed 2015·Granted Apr 3, 2018·3 cites·8 claims
- 1881US9073873B22-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseasesEDISON PHARMACEUTICALS INC·Filed 2014·Granted Jul 7, 2015·4 cites·17 claims
- 1979US11840497B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesPTC THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·0 cites·13 claims
- 2076US11312697B2Process for the production of alpha-tocotrienol and derivativesPTC THERAPEUTICS INC·Filed 2018·Granted Apr 26, 2022·0 cites·22 claims
- 2175US7151116B2Apoptolidin analogs and derivatives for inducing apoptosis in transformed cellsUNIV LELAND STANFORD JUNIOR·Filed 2004·Granted Dec 19, 2006·9 cites·56 claims
- 2273US2022133648A1Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinonesPTC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2372US2020360302A1Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinonesPTC THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2471US10968166B24-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesPTC THERAPEUTICS INC·Filed 2018·Granted Apr 6, 2021·0 cites·9 claims
- 2567US10167251B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesBIOELECTRON TECH CORP·Filed 2016·Granted Jan 1, 2019·0 cites·33 claims
- 2667US2014221674A1Process for the production of alpha-tocotrienol and derivativesEDISON PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2766US9546132B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesEDISON PHARMACEUTICALS INC·Filed 2015·Granted Jan 17, 2017·0 cites·12 claims
- 2857US2012108547A1Inhibitors of tyrosine kinases and uses thereofJANKOWSKI ORION D·Filed 2011·Application pending·0 cites
- 2957US2012101065A1Inhibitors of tyrosine kinases and uses thereofJANKOWSKI ORION D·Filed 2011·Application pending·0 cites
- 3056US2012083470A1Inhibitors of tyrosine kinases and uses thereofJANKOWSKI ORION D·Filed 2011·Application pending·0 cites
- 3143US2004006867A1Electrical devices containing conductive polymersFiled 2003·Application pending·0 cites
- 3238US2014031432A1Treatment of mitochondrial diseases with vitamin kJANKOWSKI ORION D·Filed 2011·Application pending·0 cites
- 3338US2013345312A1Treatment of mitochondrial diseases with naphthoquinonesJANKOWSKI ORION D·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Orion D. Jankowski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →